Skip to main content
BMC Medical Genomics logoLink to BMC Medical Genomics
. 2021 May 1;14:118. doi: 10.1186/s12920-021-00961-8

Ancestry specific associations of a genetic risk score, dietary patterns and metabolic syndrome: a longitudinal ARIC study

Dale S Hardy 1,, Susan B Racette 2, Jane T Garvin 3, Hirut T Gebrekristos 1, Tesfaye B Mersha 4
PMCID: PMC8088631  PMID: 33933074

Abstract

Background

Associations have been observed among genetic variants, dietary patterns, and metabolic syndrome (MetS). A gap in knowledge is whether a genetic risk score (GRS) and dietary patterns interact to increase MetS risk among African Americans. We investigated whether MetS risk was influenced by interaction between a GRS and dietary patterns among Whites and African Americans. A secondary aim examined if molecular genetic clusterings differed by racial ancestry.

Methods

We used longitudinal data over 4-visits (1987–1998) that included 10,681 participants aged 45–64y at baseline from the Atherosclerosis Risk in Communities study (8451 Whites and 2230 African Americans). We constructed a simple-count GRS as the linear weighted sum of high-risk alleles (0, 1, 2) from cardiovascular disease polymorphisms from the genome-wide association studies catalog associated with MetS risk. Three dietary patterns were determined by factor analysis of food frequency questionnaire data: Western, healthy, and high-fat dairy. MetS was defined according to the 2016 National Cholesterol Education Program Adult Treatment Panel III criteria but used 2017 American Heart Association/American College of Cardiology criteria for elevated blood pressure. Analyses included generalized linear model risk ratios (RR), 95% confidence intervals (CI), and Bonferroni correction for multiple testing.

Results

The Western dietary pattern was associated with higher risk for MetS across increasing GRS tertiles among Whites (p < 0.017). The high-fat dairy pattern was protective against MetS, but its impact was most effective in the lowest GRS tertile in Whites (RR = 0.62; CI: 0.52–0.74) and African Americans (RR = 0.67; CI: 0.49–0.91). Among each racial group within GRS tertiles, the Western dietary pattern was associated with development and cycling of MetS status between visits, and the high-fat dairy pattern with being free from MetS (p < 0.017). The healthy dietary pattern was associated with higher risk of MetS among African Americans which may be explained by higher sucrose intake (p < 0.0001). Fewer genes, but more metabolic pathways for obesity, body fat distribution, and lipid and carbohydrate metabolism were identified in African Americans than Whites. Some polymorphisms were linked to the Western and high-fat dairy patterns.

Conclusion

The influence of dietary patterns on MetS risk appears to differ by genetic predisposition and racial ancestry.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12920-021-00961-8.

Keywords: Genetic risk score, Polymorphism, Dietary patterns, Interaction, Metabolic syndrome, Race, Ancestry

Background

Metabolic syndrome (MetS) is a condition that approximately doubles the risk of incident type 2 diabetes and cardiovascular disease [1, 2], and increases mortality risk over fourfold [3]. MetS is characterized by clusters of ≥ 3 metabolic traits as defined by National Cholesterol Education Program Adult Treatment Panel III criteria: abnormal fasting blood glucose levels, central obesity, dyslipidemia, and elevated blood pressure [4]. Higher body mass index (BMI) and current cigarette smoking are associated with higher risk for MetS [5]. The prevalence of MetS is higher in older adults and in those with low levels of physical activity [6]. The etiology of MetS is complex, but reports have shown that genetic polymorphisms [712], dietary patterns [1317], and physical activity play a role in its pathogenesis.

Genetic risk scores (GRSs) composed of single nucleotide polymorphisms (SNPs) have been associated with higher risk of MetS and cardiovascular diseases. A GRS was associated with MetS risk, type 2 diabetes, obesity, and cardiovascular diseases in several studies [1830]. A GRS was associated with MetS risk in Koreans, but more in Korean females than Korean males [18]. GRSs for type 2 diabetes were associated with a Western dietary pattern in men [19], and mediated 9% risk of type 2 diabetes between parent and offspring [20]. Other GRSs for obesity risk were associated with BMI and obesity in European ancestry (Whites) and African Americans [21], predicted posttraumatic stress disorder-related MetS [22], and increased MetS risk in Chinese children [23]. Another study showed that a GRS composed of coronary artery disease SNPs was associated with not only coronary heart disease, but stroke, peripheral vascular disease, heart failure, and atrial fibrillation [24]. There is evidence that polymorphisms from the FTO alpha-ketoglutarate dependent dioxygenase (renamed from fat mass and obesity-associated FTO): rs9939609, rs8050135, and rs1420185 are associated with higher risk for MetS [3133].

Various mechanisms have been proposed regarding the influence of dietary patterns on development of MetS, but these mechanisms have not been fully elucidated. Evidence from observational studies suggests that meat, fried foods, and diet soda increase the risk of incident MetS [8, 9, 34, 35], whereas higher intakes of fruits, vegetables, and whole grains have protective associations with MetS and its components [7, 11, 36]. Dietary patterns provide a comprehensive depiction of typical eating habits which may be more informative than analyses of individual foods. Most importantly, studies have shown that Western dietary patterns that were comprised of fried foods, soda, meat, and alcohol were associated with MetS risk [1317].

Studies have reported interactions between a GRS, SNPs and dietary patterns. Qi et al. [19] reported that a Western dietary pattern increased the risk of type 2 diabetes and the highest risk was in the highest GRS tertile. Other studies reported that a GRS and a diet score increased the risk for obesity in Whites [37]. Interaction was present for rs10738760, a SNP of Vascular Endothelial Growth Factor, and high fat and sugar intake to increase risk for MetS [38]. Other interactions were reported for FTO rs9939609 with protein and carbohydrate intake on BMI [39]. Other studies reported that homozygous carriers for FTO SNPs: rs9939609, rs17817449, rs8050136 were associated with carbohydrate and protein intake in Whites and African Americans and rs8050136 with fat intake in Whites [40]. In addition, Angiopoietin-like 4 protein (ANGPTL4) interacted with carbohydrate intake to increase HDL cholesterol levels [41, 42].

Although MetS is influenced by genetics and dietary patterns, the potential pathways linking them have not been examined systematically in a population-based study. In this study, we investigated whether a GRS interacted with dietary patterns to increase MetS risk among Whites and African Americans followed over 11 years. A secondary aim was to investigate whether the molecular genetic clusterings associated with MetS differed by racial ancestry.

Methods

Study population

Atherosclerosis Risk in Communities (ARIC) study data at baseline (1987–1989) and three follow-up visits (1990–1992, 1993–1995, and 1996–1998) were obtained from the database of Genotypes and Phenotypes (dbGaP) [43]. The ARIC study, sponsored by the National Heart, Lung, and Blood Institute, is a large-scale, ongoing prospective cohort study conducted in four U.S. communities: Jackson, MS; Forsyth County, NC; Minneapolis, MN; and Washington County, MD. ARIC was designed to investigate the etiology and natural history of atherosclerosis, as well as the etiology of clinical atherosclerotic diseases and their sequelae. The overall participation rate was 60%, including 42% and 49% of eligible African American men and women, respectively, and 67% and 68% of eligible White men and women respectively, who were 45 to 64 years old [44]. All participants signed an informed consent document. Further design and sampling methods are explained elsewhere [45]. The current study was approved by the Social & Behavioral Institutional Review Board at Morehouse School of Medicine.

Inclusion of participants into the study

The original ARIC sample included 14,928 participants at baseline. We imputed missing observations on cigarette smoking, drinking status, sports physical activity and education level to augment our sample, especially for African Americans. Imputations were < 2% of the original participant sample. Figure 1 below depicts how participants were allocated into the study. To assimilate a sample population with physiologic blood pressure values, participants were excluded from the analysis at baseline and follow-up if they had systolic blood pressure < 80 mmHg (n = 54), diastolic blood pressure < 45 mmHg (n = 168), a difference of < 20 mmHg between systolic and diastolic blood pressures (n = 23), or mean arterial pressure < 60 mmHg (n = 24). Additional participants were excluded if they had missing observations at baseline for MetS component risk factors (n = 315), dietary food groups or total calories (n = 687), SNPs (n = 1526), or 20 genetic principal components to correct for population admixture (n = 1450). After excluding individuals with missing observations on food variables at baseline, there were no observations that had caloric intake < 600 or > 4200 kcal/day for men, and < 500 or > 3600 kcal/day for women. Our final models at baseline included 10,681 participants, of which 8451 (79.1%) were White and 2230 (20.9%) were African American.

Fig. 1.

Fig. 1

Entry of participants into the study and partitioned for analysis by racial ancestry. ARIC, Atherosclerosis Risk in Communities; MetS, metabolic syndrome; GRS, genetic risk score; PCA, principal components analysis

Food frequency questionnaire

A 66-item semi-quantitative food frequency questionnaire (FFQ) was used to obtain information on dietary intake. The FFQ was a modified version of the 61-item FFQ developed and validated by Willett et al. [46]. At the examination interview, participants were shown standard serving sizes and typical servings using food models to help them estimate intake. Participants reported their intake based on 9 levels of frequency, ranging from < 1 time per month to ≥ 6 times per day and were asked additional information such as brand names. The FFQ was administered during the first study visit (1987–1989) and the third study visit (1993–1995); a sub-sample of participants also completed the FFQ at the second visit (n = 1004). For participants without FFQ data at visit 2, we carried forward FFQ visit 1 data. Likewise, because the FFQ was not administered at ARIC visit 4, visit 3 FFQ data were carried forward to visit 4. The justification for this approach is that studies have shown that there is little change in dietary and physical activity patterns over a short-term, even after a cardiovascular event [55, 56].

Dietary patterns by racial ancestry

From our FFQ data, three dietary patterns emerged based on factor analysis, with the principal components factor option, varimax rotation, and a correlation ≥ 0.3: Western, healthy, and high-fat dairy. Briefly, we conducted factor analysis from 39 food or food groups based on 66 predefined foods or food groups from ARIC FFQs by racial ancestry. The dietary pattern scores were calculated by summing the standardized intakes of the component foods, weighted by the factor loadings of the foods. The dietary pattern scores rank participants according to the degree to which they adhere to the corresponding dietary patterns. Additional file 1: Table S1 shows the food groups used to form the dietary patterns, and Additional file 1: Table S2 shows the food groups and their factor loadings ≥ 0.3 by racial ancestry. Dietary patterns were chosen based on how the foods clustered together (Additional file 1: Table S2). A Western dietary pattern among Whites was characterized by red and processed meat, chicken with skin, and fried foods; among African Americans, processed meat and fried foods were more prevalent. A healthy dietary pattern consisted of rice, pasta, vegetables, chicken without skin, and lentils/ beans among Whites; among African Americans, there was a greater variety of foods. The high-fat dairy pattern included whole milk and butter and was similar for both racial ancestry groups. The proportions of total carbohydrate, protein and fat intake as a percentage of calories were not significantly different among Whites and African Americans. However, the median sucrose intake (g) differed between the racial ancestry groups (Whites: 39.2% vs. African Americans: 45.8%; p < 0.0001).

From our factor analysis, we labelled the first, second and seventh factors for Whites and the fourth, second, and ninth factors for African Americans as Western, healthy and high-fat dairy patterns, respectively. The variance/percent variance explained for the respective patterns were 2.6/6.5%, 2.0/5.0%, and 1.4/3.5% for Whites and 1.8/4.6%, 2.9/7.3%, and 1.4/4.5% for African Americans.

DNA extraction and genotyping

Genotyping was performed on whole blood using the TaqMan assay (Applied Biosystems, Foster City, CA, USA), the Affymetrix 6.0 single nucleotide polymorphism array, and the Birdseed calling algorithm [47] at the Broad Institute Center for Genotyping and Analysis. Allele detection was carried-out using the ABI Prism 7700 Sequence Detection System (Applied Biosystems).

Construction of the GRS

We compiled 16,495 SNPs chosen from preselected reference risk alleles associated with MetS, its components, and cardiovascular disease from the NHGRI GWAS catalog to compute a risk-raising allele GRS by racial ancestry [1, 48, 49]. The ARIC GWAS data yielded 397 SNPs. We then regressed MetS against each of the 397 SNPs, adjusted for age and sex by racial ancestry. SNPs with p value < 0.1 were chosen to be included in the GRS. We calculated the GRS using a simple count method as a variable whose values were equal to the number of copies of the high-risk allele under the additive model (0, 1, 2). Cardiovascular diseases searched in the NHGRI GWAS catalog were ‘metabolic syndrome, components of MetS and related phenotypes (glucose, triglycerides, high blood pressure, waist circumference, BMI, HDL cholesterol, lipids), diabetes, type 2 diabetes, stroke, coronary heart disease, peripheral artery or vascular disease, insulin resistance, inflammation, and psychological disorders linked with excessive food intake (gorging, bipolar disorder, bulimia). Additional file 1: Tables S3A and S3B show the chromosomes, SNPs, and genes used in the GRSs by racial ancestry. Most SNPs mapped to genes with lipid phenotypes such as total cholesterol, triglycerides, and HDL cholesterol.

For SNPs within high linkage disequilibrium ≥ 0.8, tag SNPs were chosen based on higher binding capacity [50]. The Hardy–Weinberg test for all SNPs was performed in Plink [49] using chi-square goodness-of-fit test for Whites and African Americans separately. All SNPs chosen for the GRS for Whites and African Americans were found to be in Hardy–Weinberg equilibrium (p > 0.05). The 20 genetic principal components were computed in Linux using gcta64 guidelines [51] to calculate a genetic-related matrix by racial ancestry and then specifying the principal components.

Study variables

The primary outcome was MetS, defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria, as clusters of ≥ 3 cardiovascular disease risk factors that include abdominal obesity based on waist circumference (men: > 102 cm, women: > 88 cm), elevated fasting blood glucose (≥ 100 mg/dL), elevated blood pressure based on the 2017 guidelines of the American Heart Association/American College of Cardiology (AHA/ACC) (≥ 120 mmHg systolic or ≥ 80 mmHg diastolic or taking blood pressure medications) [52], low HDL cholesterol (men: < 40 mg/dL, women: < 50 mg/dL), and high triglycerides (≥ 150 mg/dL) [1, 53, 54]. The main predictor variable was the GRS that was constructed using values equal to the number of copies of the high-risk allele under the additive model (0, 1, 2).

The interaction variables were the GRS and dietary patterns (described in detail above). The stratification variable was racial ancestry, defined as White or African American based on self-report. The following participant characteristics were considered for covariate adjustment to create a covariate summary score: age (continuous), gender, educational status at visit 1, cigarette smoking status (never/ former/ current), alcohol drinking status (never/ former/ current), physical activity from the Baecke questionnaire (sports physical activity, a continuous variable) [57], and study visit, an ordinal variable (1 to 4) that depicts time in the study. As with the FFQ, because physical activity was collected at visits 1 and 3 only, we carried forward physical activity Baecke scores from visit 1 to visit 2, and from visit 3 to visit 4. We did not include BMI in covariate adjustment because BMI is in the causal pathway of the dietary patterns and MetS outcome.

Statistical analysis

We regressed MetS against each SNP by racial ancestry (White or African American). SNPs with a p value < 0.1 were chosen for inclusion in the GRS. We computed a covariate summary score by regressing MetS on the covariates (age, gender, physical activity, education level at visit 1, cigarette smoking status, drinking status, study visit, and 20 genetic principal components for admixture) and then predicted the residuals. Analyses were performed using generalized linear model with Poisson family and log link to derive risk ratios (RR) and 95% confidence intervals (CI), after applying within-subject identification to specify responses that were nested in the participant in order to compute the cumulative effect of the GRS and/or dietary pattern over time. In our generalized linear model analysis, we were interested in the expectation of the outcome, MetS, as a function of the GRS and/or the dietary pattern adjusted for the covariate summary score. In our multivariate models, we regressed MetS on the GRS and/or each dietary pattern, adjusting for the covariate summary score.

We tested whether there was additive interaction (biological interaction) between the GRS and dietary patterns on the additive risk scale. In additive interaction models, we included the GRS, dietary pattern score, interaction term composed of the GRS and the dietary pattern, along with the covariate summary score for adjustment. To determine whether there was additive interaction, the GRS, dietary pattern, and their interaction term all had to be statistically significant at p < 0.05 using the Wald test [58]. All analyses were reported as per 5-increment increase in dietary pattern scores by GRS tertiles. In all models, a 2-sided p < 0.05 and more stringent, Bonferroni adjustment for multiple testing of p < 0.017 were used as the threshold for statistical significance in the final models. All regression analyses were bootstrapped 10,000 times. Our statistical analyses were conducted using Stata MP, version 16.0 (StataCorp, College Station, TX).

Literature Lab™-based clustering

A secondary objective of our study was to investigate the biological relationships among the genes linked to the SNPs by racial ancestry using Literature Lab™ from Acumenta Biotech Clustering algorithm [59]. In Literature Lab™, clustering analysis is performed on the unique qualified terms (Strong, Moderate, or Positive) from domains identified in the analysis of the gene list using hierarchical clustering with uncentered correlation and average linkage, software package Cluster 3.0 (http://bonsai.hgc.jp/~mdehoon/software/cluster/software.htm). Genes were clustered on similarity in molecular function among each other.

Likewise, terms are clustered by how similarly they are related to the genes (percent of match that mention a given term and gene in PubMed). Clusters of ≥ 6 genes were then examined in decreasing order of the average intensity of the measure (percentage of gene abstracts mentioning each term). Multiple term clusters for the same gene cluster and multiple gene clusters for the same term cluster are shown together in the list of clusters and in the heatmap displays for the clusters. The selected clusters are presented both in a list of the clusters with terms and genes and in individual heat maps for each cluster. In the heat maps, yellow is used to signify intensity; the brightest yellow represents an intensity measure of 25% or more. An intensity of 0% is shown in black and intermediate intensities are shown in various shades from black to yellow.

Results

Descriptive characteristics by racial ancestry

At baseline (1987–1989), the total sample consisted of 10,681 participants (8451 (79.1%) White and 2230 (20.0%) African American) aged 45–64 years. Included in the total sample, MetS cases at baseline and during 11-years of follow-up included 43.0% and 50.5% among Whites and 49.2% and 55.8% among African Americans, respectively.

Table 1 shows the baseline characteristics of participants included in the analyses. All characteristics were significantly different between Whites and African Americans except total cholesterol and LDL cholesterol. A higher proportion of African Americans smoked cigarettes, had a high-school education or less, were on blood pressure medications or were obese; additionally, they had lower levels of physical activity, higher systolic and diastolic blood pressure, higher fasting blood glucose, and higher triglyceride levels compared to Whites. In contrast, a higher proportion of Whites were current drinkers and the mean HDL cholesterol was lower, but fewer had diabetes or MetS compared to African Americans.

Table 1.

Characteristics among Whites and African Americans at baseline (1987–1989) in ARIC

All races combined Whites African Americans P value comparing African Americans to Whites
(n = 10,681) (n = 8451) (n = 2230)
Characteristic Mean (SD) or column percent (%) of participants
Age (45–64 years) 54.2 (5.6) 54.4 (5.7) 53.6 (5.8)  < 0.0001
Female (%) 54.9 53.0 62.0  < 0.0001
Body mass index (BMI) 27.6 (5.3) 27.0 (4.8) 29.7 (6.1)  < 0.0001
Weight status (%)  < 0.0001
Underweight (BMI ≤ 18.5 kg/m2) 0.8 0.8 0.8
Normal weight (BMI 18.5–24.9 kg/m2) 33.0 36.4 20.9
Overweight (BMI 25.0–29.9 kg/m2) 39.5 40.1 37.4
Obese (BMI ≥ 30 kg/m2) 26.7 22.7 41.0
Physical activity level (1–5 Baecke units) 2.5 (.8) 2.5 (0.8) 2.1 (0.7)  < 0.0001
Cigarette smoking (%)  < 0.0001
Current 25.1 24.1 28.9
Former 33.1 35.7 24.1
Never 41.7 40.1 47.0
Alcohol intake (%)  < 0.0001
Current 58.1 65.4 32.1
Former 17.9 16.6 22.5
Never 24.0 17.9 44.4
Education level (%)  < 0.0001
Grade school or zero years of education 8.5 5.6 18.7
High school, but no degree 13.3 11.0 21.4
High school graduate 33.1 36.3 21.5
Vocational school 8.7 9.2 6.9
College 26.7 29.1 18.2
Graduate or professional school 9.9 8.9 13.4
Systolic blood pressure (mmHg) 120.9 (18.1) 118.8 (16.8) 128.5 (20.4)  < 0.0001
Diastolic blood pressure (mmHg) 73.6 (10.7) 71.8 (9.7) 79.8 (11.9)  < 0.0001
Blood pressure medications (%) 29.7 25.5 44.7  < 0.0001
Fasting blood glucose (mg/dL) 108.1 (38.4) 105.3 (30.9) 117.8 (56.6)  < 0.0001
Diabetes (%) 11.1 8.7 19.4  < 0.0001
Metabolic syndrome (%) 44.3 43.0 49.2  < 0.0001
Waist circumference (cm) 96.9 (13.7) 96.2 (13.2) 99.3 (15.1)  < 0.0001
Total cholesterol (mg/dL) 215.1 (41.8) 214.9 (40.8) 215.7 (45.1) 0.4276
LDL cholesterol (mg/dL) 137.8 (38.9) 137.6 (37.7) 138.3 (42.7) 0.3977
HDL cholesterol (mg/dL) 51.5 (17.0) 50.5 (16.8) 54.8 (17.3)  < 0.0001
Triglyceride level (mg/dL) 133.0 (92.9) 137.8 (93.7) 116.3 (83.1)  < 0.0001

ARIC, Atherosclerosis Risk in Communities study; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol

%, percent of sample. All other variable results are means

P values for proportions of categorical variables among Whites and African Americans were calculated using Pearson’s chi-square tests of hypothesis for independence and tests for differences between means of continuous variables. Analysis showed that all variables were statistically significant between each other except total cholesterol and LDL cholesterol

Association between GRS or dietary patterns and MetS

The GRS was associated with MetS in both Whites and African Americans (Table 2). Each 5-increment increase in the GRS posed higher risk for MetS among African Americans (p < 0.001). Additionally, the highest GRS tertile had the greatest risk for MetS compared to the lowest tertile among Whites (RR = 1.28; CI: 1.23–1.33, p < 0.001) and notably in African Americans (RR = 1.37; CI: 1.27–1.48; p < 0.001).

Table 2.

Association between a GRS or dietary patterns on metabolic syndrome over four visits in ARIC

Risk ratio (95% confidence interval)
Whites P value African Americans P value
(n = 8451) (n = 2230)
Genetic risk score
GRS range/mean (SD) 44–84/61.4 (5.3) 32–63/ 46.5 (4.2)
GRS per 1 allele increase 1.02 (1.02–1.03)  < 0.001 1.03 (1.02–1.04)  < 0.001
GRS per 5 increment 1.12 (1.10–1.14)  < 0.001 1.17 (1.13–1.21)  < 0.001
GRS lower tertile 1.00 (ref) 1.00 (ref)
GRS second tertile 1.12 (1.07–1.17)  < 0.001 1.23 (1.14–1.33)  < 0.001
GRS highest tertile 1.28 (1.23–1.33)  < 0.001 1.37 (1.27–1.48)  < 0.001
Dietary pattern per 5 increment
No. per dietary pattern
Western 1.21 (1.12–1.31)  < 0.001* 1.14 (0.97–1.33) .102
Healthy 1.03 (0.95–1.11) .453 1.20 (0.99–1.47) .070
High-fat dairy 0.72 (0.66–0.79)  < 0.001* 0.81 (0.69–0.96) .013*

Bold indicates p values that were significant at p < 0.05

*Bonferroni adjustment for multiple testing (p < 0.05/3 = 0.017)

Dietary patterns were calculated using factor analysis with the principal components factor option and the varimax rotation with correlation ≥ 0.3

MetS was regressed against the GRS adjusting for a covariate summary score composed of age, gender, sports physical activity (Baecke questionnaire), cigarette smoking status, drinker status, education level at visit 1, time in study, and 20 principle components for admixture

Dietary patterns are from Additional file 1: Table S2

Dietary pattern contents for Whites:

Western: fried foods, red meat, chips and fries, chicken with skin, processed meat, eggs, and condiments

Healthy: rice, pasta, vegetables, mashed potato, chicken without skin, lentils and beans

High-fat dairy: butter, whole milk, eggs

Dietary pattern contents for African Americans

Western: Eggs, processed meat, biscuit and cornbread, whole wheat bread, fried foods, white bread, and margarine-butter

Healthy: Chicken without skin, vegetables, lentils and beans, fruit, cooked breakfast cereal, fish, mashed potato, shellfish, and cold breakfast cereal

High-fat dairy: Butter, margarine-butter, whole milk, and cottage cheese

In longitudinal analyses, the Western dietary pattern increased MetS risk among Whites (RR = 1.21; CI: 1.12–1.31; p < 0.001). In contrast, the high-fat dairy pattern was associated with lower risk for MetS among Whites (RR) = 0.72; CI: 0.66–0.79; p < 0.001) and African Americans (RR = 0.81; CI: 0.69–0.96; p = 0.013); see Table 2.

Interaction between the GRS and dietary patterns on MetS

We observed interactions with the GRS and dietary patterns (Table 3). The greatest protective effects were observed for the high-fat dairy pattern in the lowest GRS tertile among Whites (RR = 0.62; CI: 0.52–0.74; p < 0.001) and African Americans (RR = 0.67; CI: 0.49–0.91; p < 0.011). However, African Americans with the greatest burden of high-risk alleles (highest GRS tertile) and those who consumed a healthy diet, had a higher risk for MetS (RR = 1.39; CI: 1.07–1.82; p = 0.015). Among African Americans, the overall effect of the GRS and the Western dietary pattern increased MetS risk (RR = 7.43; CI: 1.57–35.08; p = 0.011). However, the confidence intervals were very wide for the point estimate and appeared unstable.

Table 3.

Interaction between a GRS and dietary patterns on metabolic syndrome over four visits in ARIC

Risk ratio (95% confidence interval) P value
Dietary patterns Lowest GRS Tertile P value Second GRS Tertile P value Highest GRS Tertile P value Overall effect of diet × GRS interaction P value
Whites
No. per group 3072 2487 2892 8451
Western 1.17 (1.01–1.35) 0.031 1.28 (1.11–1.47) 0.001* 1.23 (1.09–1.38) 0.001* 1.10 (0.47–2.57) 0.831
Healthy 1.07 (0.92–1.23) 0.383 0.98 (0.85–1.13) 0.827 1.02 (0.91–1.15) 0.679 1.04 (0.45–2.41) 0.920
High-fat dairy 0.62 (0.52–0.74)  < 0.001* 0.74 (0.63–0.87)  < 0.001* 0.81 (0.71–0.91) 0.001* 0.26 (0.10–0.70) 0.008*
African Americans
No. per group 710 795 725 2230
Western 1.46 (1.04–2.04) 0.028 1.18 (0.93–1.50) 0.174 0.89 (0.70–1.13) 0.329 7.43 (1.57–35.08) 0.011*
Healthy 1.15 (0.73–1.81) 0.549 1.09 (0.80–1.48) 0.597 1.39 (1.07–1.82) .015* 1.25 (0.15–10.08) 0.837
High-fat dairy 0.67 (0.49–0.91) 0.011* 0.71 (0.533–0.96) 0.024 1.03 (0.81–1.29) 0.828 0.17 (0.03–0.88) 0.035

Bold indicates p values that were significant at p < 0.05

*Bonferroni adjustment for multiple testing for dietary patterns (p = 0.05/3 = 0.017)

Dietary patterns were calculated using factor analysis with the principal components factor option and the varimax rotation with correlation ≥ 0.3

MetS was regressed against the GRS adjusting for covariate summary score composed of age, gender, sports physical activity (Baecke questionnaire), cigarette smoking status, drinker status, education level at visit 1, time in study, and 20 principle components for admixture

Dietary patterns are from Additional file 1: Table S2

Dietary pattern contents for Whites:

Western: fried foods, red meat, chips and fries, chicken with skin, processed meat, eggs, and condiments

Healthy: rice, pasta, vegetables, mashed potato, chicken without skin, lentils and beans

High-fat dairy: butter, whole milk, eggs

Dietary pattern contents for African Americans:

Western: Eggs, processed meat, biscuit and cornbread, whole wheat bread, fried foods, white bread, and margarine-butter

Healthy: Chicken without skin, vegetables, lentils and beans, fruit, cooked breakfast cereal, fish, mashed potato, shellfish, and cold breakfast cereal

High-fat dairy: Butter, margarine-butter, whole milk, cottage cheese

Association between dietary patterns and resolution or development of MetS

Because MetS is comprised of individual risk factors that can improve or worsen over time, participants may have resolution or development MetS during the 11 years of follow-up. We investigated the association of dietary patterns and whether participants became free of MetS at visit 4 or developed MetS at visit 4 after having MetS at visit 1 or were free of MetS at visit 1. In these analyses, participants’ MetS status change was in one direction only from visits 1 to 4. Figure 2 and Additional file 1: Table S4 show the associations of dietary patterns with resolution or development of MetS at visit 4 by racial ancestry. Compared to those who did not have MetS at all four visits, the Western dietary pattern increased MetS risk among Whites: RR = 1.64; CI: 1.44–1.86; p < 0.001; n = 4499 for those with MetS at all four visits; RR = 1.42; CI: 1.19–1.69; p < 0.001, for those who were free of MetS at visit 1 and risk of developing MetS at visit 4 (n = 4110); and RR = 1.60; CI: 1.28–2.00; p = 0.001; n = 3696 for those who had MetS at visit 1 and risk of being free from MetS at visit 4.

Fig. 2.

Fig. 2

Association between dietary patterns and developing MetS or being free from metabolic syndrome among Whites and African Americans. Participants’ MetS status change was in one direction only from visits 1 to 4. Key +  +  +  + versus −  −  −  −: Those with MetS at all 4 visits compared with those without MetS at all 4 visits; − # versus −  −  −  −: Those free of MetS at visit 1 but developed MetS at visit 4 compared with those without MetS at all 4 visits; +  = versus −  −  −  −: Those with MetS at visit 1 but free of MetS at visit 4 compared with those without MetS at all 4 visits. Bold indicates p values that were significant at p < 0.05. Bonferroni adjustment for multiple testing for dietary patterns (p = 0.05/4 = 0.017). Dietary patterns were calculated using factor analysis with the principal components factor option and the varimax rotation with correlation ≥ 0.3. MetS was regressed against the GRS adjusting for a covariate summary score composed of age, gender, sports physical activity (Baecke questionnaire), cigarette smoking status, drinker status, education level at visit 1, time in study, and 20 genetic principle components for admixture. Dietary patterns are from Additional file 1: Table S2. Dietary pattern contents for Whites: Western: fried foods, red meat, chips and fries, chicken with skin, processed meat, eggs, and condiments; Healthy: rice, pasta, vegetables, mashed potato, chicken without skin, lentils and beans; High-fat dairy: butter, whole milk, eggs. Dietary pattern contents for African Americans: Western: Eggs, processed meat, biscuit and cornbread, whole wheat bread, fried foods, white bread, and margarine-butter; Healthy: Chicken without skin, vegetables, lentils and beans, fruit, cooked breakfast cereal, fish, mashed potato, shellfish, cold breakfast cereal; High-fat dairy: Butter, margarine-butter, whole milk, cottage cheese

In contrast, high-fat diary pattern consistently showed a protective association among Whites.

Compared to those who did not have MetS at all four visits, the relative risks were decreased in the following amounts: RR = 0.59; CI: 0.50–0.69; p < 0.001 and risk of MetS at all four visits (n = 4999); RR = 0.73; CI: 0.61–0.88; p = 0.001; for those who were free of MetS at visit 1 and risk of developing MetS at visit 4 (4110); RR = 0.72; CI: 0.57–0.91; p = 0.006; and for those who had MetS at visit 1 and risk of being free from MetS at visit 4 (n = 3696).

Among African Americans, the healthy dietary pattern was associated with higher risk for MetS (RR = 1.65; CI: 1.15–2.16; p ≤ 0.001; n = 1010) for those who had MetS at all four visits. The high-fat dairy patterns showed significant protective risks: RR = 0.66; CI: 0.45–0.98; p = 0.038; n = 1026 among those who had MetS at visit 1 and risk of being free from MetS at visit 4. However, the latter estimates did not meet the Bonferroni threshold or multiple testing (p < 0.017).

Interaction between the GRS and dietary patterns and resolution or development of MetS

We investigated whether the GRS and dietary patterns interact to influence MetS risk beyond their independent associations. As in association analyses above, participants’ MetS status change was in one direction only from visits 1 to 4. We present results only for dietary patterns that showed significant associations with the GRS in Fig. 3. Additional file 1: Tables S5A and S5B show all significant and non-significant associations for dietary patterns and GRS tertiles by racial ancestry. We scaled dietary patterns as per 5-increment within the GRS tertiles. As in the association analysis, in all these analyses, the comparator was those who did not have MetS at any of the four visits. Among Whites who had MetS at all four visits (n = 4499), we observed higher risks for the Western dietary pattern within the GRS tertiles (p values for GRS tertiles 1, 2 and 3: 0.003, 0.001, 0.001, respectively). Conversely, in spite of the risk-raising GRS, the protective effects of high-fat dairy in the interaction remain among Whites for decreased risk of MetS at all four visits (p values for GRS tertiles 1, 2 and 3: 0.001, 0.003, 0.001, respectively; overall interaction effect: RR = 0.08; CI: 0.01–0.47; p = 0.005). However, the greatest protection for the high-fat dairy pattern was in the lowest GRS tertile for Whites (RR = 0.47; CI: 0.33–0.66; p ≤ 0.001; n = 1637) and African Americans (only significant in the lowest tertile; RR = 0.67; CI: 0.50–0.91; p ≤ 0.009; n = 1661) who were free of MetS at visit 1 and risk of developing MetS at visit 4.

Fig. 3.

Fig. 3

Interactions between a GRS and dietary patterns for developing MetS or being free from metabolic syndrome among Whites and African Americans. Participants’ MetS status change was in one direction only from visits 1 to 4. Key: +  +  +  + versus −  −  −  −: Those with MetS at all 4 visits compared with those without MetS at all 4 visits; − # versus −  −  −  −: Those free of MetS at visit 1 but developed MetS at visit 4 compared with those without MetS at all 4 visits; +  = versus −  −  −  −: Those with MetS at visit 1 but free of MetS at visit 4 compared with those without MetS at all 4 visits. Bold indicates p values that were significant at p < 0.05. Bonferroni adjustment for multiple testing for dietary patterns (p = 0.05/3 = 0.017). Dietary patterns were calculated using factor analysis with the principal components factor option and the varimax rotation with correlation ≥ 0.3. MetS was regressed against the GRS adjusting for a covariate summary score composed of age, gender, sports physical activity (Baecke questionnaire), cigarette smoking status, drinker status, education level at visit 1, time in study, and 20 genetic principle components for admixture

Among African Americans who had MetS at visit 1 but were free of MetS at visit 4 compared to participants without MetS at all 4-visits, there was a protective effect of high-fat dairy intake in the second tertile (RR = 0.33; CI: 0.15–0.68); p = 0.003; n = 367; overall interaction effect: RR = 0.0076; CI: 0.0002–0.3372; p = 0.012; n = 1026). The lowest GRS tertile (RR = 0.45; CI: 0.21–0.94; p = 0.033; n = 358) was statistically significant but did not met Bonferroni correction for multiple testing (p < 0.017). Moreover, in the highest GRS tertile for those who had MetS at all four visits, the healthy dietary pattern was associated with increased MetS risk (RR = 2.08; CI: 1.48–2.92; p < 0.001; n = 310). In addition, there was a harmful effect of the healthy dietary pattern for those who had MetS at visit 1 and risk of being free from MetS at visit 4 (RR = 3.61; CI: 1.66–7.87; p < 0.001; n = 240).

Association between dietary patterns for those who had resolution or development of MetS whose MetS status cycled between visits 1 and 4

We investigated the association of dietary patterns in participants whose MetS status cycle between visits 1 through 4. Additional file 1: Table S6 shows the associations for dietary patterns and associations with MetS among MetS status cyclers by racial ancestry. In these analyses, participants reverted back-and-forth from being free of MetS to having MetS or vice-versa from visits 1 to 4. Participants were free from or had MetS at visit 1. Among Whites, the Western dietary pattern was associated with higher risk for MetS at visit 4 (RR = 1.66; CI: 1.30–2.12; p < 0.001; n = 3477); as well as less likely to remain free from MetS at visit 4 (RR = 1.43; CI: 1.13–1.81; p = 0.003; n = 3706). However, the magnitude of effect was higher for Whites for the former association. High-fat dairy intake was associated with decreased risk of MetS in Whites (RR = 0.76; CI: 0.60–0.96; p = 0.019; n = 3706) and African Americans (RR = 0.66; CI: 0.45–0.96; p = 0.028; n = 986) and the likelihood of being free from MetS at visit 4, but this association did not meet the Bonferroni threshold cutoff of p < 0.017.

Interaction between a GRS and dietary patterns for those who had resolution or development of MetS whose MetS status cycled between visits 1 and 4

We investigated the interaction between the GRS and dietary patterns in participants whose MetS status cycle between visits 1 through 4. Additional file 1: Table S7A and S7B show the interactions of a GRS and dietary pattern associations with MetS among MetS status cyclers by racial ancestry. As stated above, in these analyses, participants reverted back-and-forth from being free of MetS to having MetS or vice-versa. In these analyses we combined participants who were free from or had MetS at visit 1 to augment our sample. We observed higher risks for MetS at visit 4 among Whites in the lowest (RR = 1.77; CI: 1.19–2.74; p = 0.005; n = 1394) and highest (RR = 1.72; CI: 1.18–2.52; p = 0.005; n = 1.020) GRS tertiles for the Western pattern. Similarly, there was a less likelihood for being free from MetS at visit 4 in the highest GRS tertile for the Western dietary pattern (RR = 1.68; CI: 1.14–2.47; p = 0.008; n = 1094). In contrast, the high-fat dairy pattern was protective of MetS in the lowest GRS tertile and showed a decreased risk of MetS at visit 4 (RR = 0.51; CI: 0.32–0.81; p < 0.004; n = 1394); and for those who remained free of MetS at visit 4 (RR = 0.64; CI: 0.44–0.95; p = 0.027; n = 1490), but the latter association did not meet the Bonferroni threshold for multiple testing (p < 0.017).

Among African Americans whose MetS status cycled between visits 1 to 4, we observed the harmful effects of the Western dietary pattern was significant only in the highest GRS tertiles for those who had MetS at visit 4 (RR = 0.32; CI: 0.16–0.67; p = 0.002; n = 227). The high-fat dairy pattern was protective in the second GRS tertile and showed a favorable risk of being free from MetS at visit 4 (RR = 0.46; CI: 0.24–0.89; p = 0.20; n = 354), but the association did not meet the Bonferroni threshold for multiple testing (p < 0.017).

Molecular genetic clustering pathway analysis

We used Literature Lab™ clustering analysis to find functional relationship differences among the genes by racial ancestry. Fewer genes but more metabolic pathways were found in African Americans than Whites (Figs. 4 and 5). In general, the top pathways for African Americans included pathways that were identified in Whites, as well as additional pathways for obesity and related body fat distribution, and lipid and carbohydrate metabolism. This may indicate that mechanisms involving gene-diet and disease risks may be more complex among African Americans than Whites.

Fig. 4.

Fig. 4

Molecular genetic clustering pathways for Whites. Molecular genetic clustering pathway analysis was performed using Literature Lab™ clustering software to find functional relationship differences among the genes by racial ancestry

Fig. 5.

Fig. 5

Molecular genetic clustering pathways for African Americans. Molecular clustering genetic pathway analysis was performed using Literature Lab™ clustering software to find functional relationship differences among the genes by racial ancestry

The top five pathways by association for Whites were linoleic acid with FAD1 (26.0%) and FAD2 (67.5%), regulation of insulin secretion with insulin (88.7%), type 2 diabetes with insulin (78.5%), pancreatic secretion with insulin (70.9%), and fatty acid elongation with FAD1 (38.8%) and FAD2 (60.1%). See Table 4 for abbreviations of gene symbols and their names. When we categorized pathways by the most significant p values, the top pathways for Whites were CHREBP and MLXIPL (99.2%), vitamin D receptor and vitamin D (99.8%), and GCPRs-Class A Rhodopsin-Like and Rhodopsin (100%). For African Americans the top pathways by association were, CHREBP and MLXIPL (99.6%), G-Alpha signaling (99.9%) and BDNF (99.9%) with GNAS. The top five strongest pathways by most significant p values for African Americans were linoleic acid metabolism with FAD2 (66.7%) and FAD1 (26.8%) genes, followed by insulin secretion and type 2 diabetes with insulin pathway (86.1% and 83.1%), respectively, in addition to vitamin A and carotenoid metabolism with CY26A1 (55%) and ALDH1A2 (38.6%), and maturity onset diabetes with insulin (82.2%).

Table 4.

Abbreviations of gene symbols and their names

Gene symbol Gene name
ABCA1 ATP binding cassette subfamily A member 1
ABCB11 ATP binding cassette subfamily B member 11
ABCG2 ATP binding cassette subfamily G member 2 (Junior blood group)
ABO ABO, alpha 1–3-N-acetylgalactosaminyltransferase and alpha 1–3-galactosyltransferase
AC9 Adenylate cyclase 9
ACAN Aggrecan
ACO Kallikrein related peptidase 15
ADIPOQ Adiponectin, C1Q and collagen domain containing
ALDH1A2 Aldehyde dehydrogenase 1 family member A2
APOA5 Apolipoprotein A5
APOB Apolipoprotein B
AS1 Prostaglandin D2 receptor
ATF6B Activating transcription factor 6 beta
BAZ1B Bromodomain adjacent to zinc finger domain 1B
BCL2 BCL2 apoptosis regulator
BCL2A1 BCL2 related protein A1
BCL7B BAF chromatin remodeling complex subunit BCL7B
BDNF Brain derived neurotrophic factor
CALM2 Calmodulin 2
CAPZA1 Capping actin protein of muscle Z-line subunit alpha 1
CCBL2 Kynurenine aminotransferase 3
CCK Cholecystokinin
CDKAL1 CDK5 regulatory subunit associated protein 1 like 1
CDKN2A Cyclin dependent kinase inhibitor 2A
CDKN2B Cyclin dependent kinase inhibitor 2B
CELSR2 Cadherin EGF LAG seven-pass G-type receptor 2
CETP Cholesteryl ester transfer protein
CILP2 Cartilage intermediate layer protein 2
CLCN6 Chloride voltage-gated channel 6
CLEC16A C-type lectin domain containing 16A
CYP26A1 Cytochrome P450 family 26 subfamily A member 1
CYP26C1 Cytochrome P450 family 26 subfamily C member 1
EDEM2 ER degradation enhancing alpha-mannosidase like protein 2
Eos Eosinophilia, familial
ERBB3 Erb-b2 receptor tyrosine kinase 3
FADS1 Fatty acid desaturase 1
FADS2 Fatty acid desaturase 2
FTO FTO alpha-ketoglutarate dependent dioxygenase (fat Mass and obesity-associated)
G6PC2 Glucose-6-phosphatase catalytic subunit 2
GCK Glucokinase
GCKR Glucokinase regulator
GIPR Gastric inhibitory polypeptide receptor
GNAS GNAS complex locus
GSS Glutathione synthetase
HERPUD1 Homocysteine inducible ER protein with ubiquitin like domain 1
HFE Homeostatic iron regulator
HIGD1C HIG1 hypoxia inducible domain family member 1C
HIST1H4C H4 clustered histone 3
HMGA2 High mobility group AT-hook 2
HNF4A Hepatocyte nuclear factor 4 alpha
IGF2 Insulin like growth factor 2
IGF2AS IGF2 antisense RNA
IKZF4 IKAROS family zinc finger 4
INS Insulin
ISCA2 Iron-sulfur cluster assembly 2
KCNQ1 Potassium voltage-gated channel subfamily Q member 1
KCNQ1OT1 KCNQ1 opposite strand/antisense transcript 1
KIAA0350 C-type lectin domain containing 16A
KLHL8 Kelch like family member 8
LCAT Lecithin-cholesterol acyltransferase
LGR5 Leucine rich repeat containing G protein-coupled receptor 5
LINC02702 Long intergenic non-protein coding RNA 2702
LIPC Lipase C, hepatic type
LPL Lipoprotein lipase
HLA Class III Caspase 7
MIR499A microRNA 499a
MLXIP MLX interacting protein
MLXIPL MLX interacting protein like
MOV10 Mov10 RISC complex RNA helicase
MTHFR Methylenetetrahydrofolate reductase
MYH7B Myosin heavy chain 7B
NAT2 N-acetyltransferase 2
NCAN Neurocan
NPC2 NPC intracellular cholesterol transporter 2
NPPB Natriuretic peptide B
NUP93 Nucleoporin 93
PBX4 PBX homeobox 4
PDE3A Phosphodiesterase 3A
PDILT Protein disulfide isomerase like, testis expressed
PKD2 Polycystin 2, transient receptor potential cation channel
PKN2 Protein kinase N2
PPARG Peroxisome proliferator activated receptor gamma
PRKAG2 Protein kinase AMP-activated non-catalytic subunit gamma 2
PROCR Protein C receptor
PSRC1 Proline and serine rich coiled-coil 1
RELA RELA proto-oncogene, NF-kB subunit
RETN Resistin
RHBG Rh family B glycoprotein (gene/pseudogene)
RNA5SP483 RNA, 5S ribosomal pseudogene 483
RNU6-407P RNA, U6 small nuclear 407, pseudogene
RP11 Pre-mRNA processing factor 31
RP11-356I2.2 Long intergenic non-protein coding RNA 2539
RP4 Rhodopsin
SIPA1 Signal-induced proliferation-associated 1
SLC12A3 Solute carrier family 12 member 3
SNORD56 Small nucleolar RNA, C/D box 56
SORT1 Sortilin 1
ST7L Suppression of tumorigenicity 7 like
STAB1 Stabilin 1
SURF6 Surfeit 6
SYN2 Synapsin II
TBL2 Transducin beta like 2
TCF7L2 Transcription factor 7 like 2
TGFBR3 Transforming growth factor beta receptor 3
TNXB Tenascin XB
TRIB1 Tribbles pseudokinase 1
TRPC4AP Transient receptor potential cation channel subfamily C member 4 associated protein
TSPAN8 Tetraspanin 8
UMOD Uromodulin
VDR Vitamin D receptor
VPS37D VPS37D subunit of ESCRT-I

We examined similarities by association among pathways for Whites compared with African Americans and found vitamin A and carotenoid metabolism with ALDH1A2 (94.7% vs. 38.6%), ketone body regulation with insulin (89% vs. 90%), fructose/mannose metabolism with MXIPL (86.2% vs. 86.3%), glucose and energy metabolism with insulin (84.3% vs. 83.7%), and unsaturated fatty acid biosynthesis with FAD2 (55.8% vs. 55.8%) and FAD1 (44.2% vs. 44.1%) were the top pathways with a nutrition focus. We examined similarities by p value among Whites compared with African Americans, and found additional genes for CHREBP and MXIPL (99.2% vs. 99.6%) and linoleic acid metabolism with FAD1 (67.5% vs. 69.7%) and FAD2 (26% vs. 26.8%).

We compared differences in the pathways among racial ancestry by score, and observed that apoptosis and insulin cellular apoptosis were the top pathways. The genes associated with these pathways were: BCL2 for Whites (92.3% and 88.4%) and African Americans RELA (38% and 30%), and PPAR for Whites (20.2% and 20.9%). We looked at differences among pathways by p value for Whites/African Americans, and found CHREBP with MXIPL (99.2% /99.6%) and linoleic acid metabolism with FAD1 (67.5% vs. 69.7%) and FAD2 (26% vs. 26.8%) were statistically significant at p < 0.0001.

Discussion

In this 11-year longitudinal study, we found that among Whites, the Western dietary pattern increased MetS risk across GRS tertiles. However, the high-fat dairy pattern was protective against MetS and its effect was strongest in the lowest GRS tertile among both racial ancestry groups. Among each racial group within GRS tertiles, the Western dietary pattern was associated with development and cycling of MetS status between visits, and the high-fat dairy pattern with being free from MetS. Fewer genes, but more metabolic pathways for obesity, body fat distribution, and lipid and carbohydrate metabolism were identified in African Americans than Whites. We found pathways for genes (FAD1/FAD2, MLXIPL) and their polymorphisms (rs174548/rs2286276, rs799165), respectively associated with a Western dietary pattern that could exacerbate MetS risk.

Higher risk for genetic traits, obesity and insulin resistance, contribute to greater risks for cardiometabolic diseases among African Americans [60]. Studies found that African Americans in general have a higher risk for type 2 diabetes and other cardiovascular diseases than Whites and greater risk for subsequent complications [60]. Our recently published study showed that African Americans have a higher prevalence of MetS compared with Whites, and that by using the 2017 AHA/ACC blood pressure guidelines, MetS prevalence has increased compared to using the previous blood pressure guidelines [52, 61].

A few studies found high-fat diary pattern to be beneficial against development of MetS [8] and type 2 diabetes [62]. Hu et al. [63] reported that the harmful Western dietary pattern was associated with development of coronary heart disease. In this study, the deleterious Western dietary pattern that was composed of fried foods, red and processed meat and sweets, increased MetS risk among Whites. Most importantly, for White participants whose MetS status cycled between visits 1 to visit 4, the Western dietary pattern and interaction with the GRS, consistently increased MetS risk.

Furthermore, within the highest GRS tertile, the healthy dietary pattern increased MetS risk among African Americans. This finding was of concern and was further investigated. Further analyses showed that the median sucrose intake (g) differed between the racial ancestry groups. Some studies show that sugar consumption increases the risk for metabolic disease [64]. High sugar intake was associated with MetS risk, type 2 diabetes, risk for overweight or obesity and cardiovascular risk factors [65, 66]. High fructose intake may be related to insulin resistance, impaired glucose tolerance, and dyslipidemia which is more prevalent among African Americans than Whites [34, 67]. Other studies show that a lower-carbohydrate higher-fat diet may be more beneficial in preventing the development of MetS and cycling of MetS status between visits [68].

Novel relationships in molecular genetic clustering pathway analysis were that of vitamin D receptor with vitamin D among Whites, CYP26A1 with vitamin A and carotenoid metabolism in African Americans, and FAD1 and FAD 2 with linoleic acid metabolism, an essential omega n-6 fatty acid, and MLXIPL with fructose/mannose metabolism among both racial ancestry groups.

Although vitamin D is known for its roles in calcium and bone metabolism, low levels of vitamin D may contribute to high fasting blood glucose, higher risk for MetS, and cardiovascular disease [69, 70]. Conversely, higher levels of vitamin D are associated with improved fasting blood glucose, reversal of insulin resistance, enhanced beta cell function, and prevention of diabetes [70, 71]. Treatment with vitamin D has been shown to abate symptoms and decrease risk of cardiometabolic diseases [69] and depression [72]. Other studies show that CY26A1 (rs4411227) was associated with vitamin A and carotenoid metabolism. Vitamin A and its’ carotenoids precursors are unsaturated fat-soluble nutrients important for vision, reproduction, immunity, cognition, and metabolism in protection against diabetes and cardiovascular diseases even among individuals with MetS who smoke, a known oxidative stressor [73, 74].

We found FAD1 and FAD2 genes were linked to rs174548, a SNP in the GRS in both Whites and African Americans. The genotype minor and major alleles can vary in different populations [75]. FAD1 and FAD2 are influential in long chain polyunsaturated acid synthesis, such as synthesis of linoleic fatty acid and arachidonic fatty acids [76, 77]. FAD1 and FAD2 genes are associated with cardiovascular diseases and other health consequences [75]. Diets rich in conjugated linoleic acid, have been shown to decrease inflammation, and consequently improve the markers of metabolic traits such as insulin sensitivity and neuropathy in diabetes [78]. Alternately, diets high in arachidonic acid are linked to pro-and inflammatory conditions that promote atherosclerotic vascular damage [75]. Farvid et al. [79] reported that higher intakes of linoleic acid, the predominant n-6 fatty acid, were associated with 13% lower risk of coronary heart disease events in a dose–response manner. The authors recommended to replace saturated fat with polyunsaturated fat for primary prevention of coronary heart disease. Habitual red meat intake was associated with higher levels arachidonic in Singapore adults [80]. Martinelli et al. [78] reported that the Western diet which carries a high ratio of arachidonic to linoleic fatty acids may be detrimental in individuals carrying the FAD genotypes linked to higher desaturase activity because they may be more prone to inflammatory conditions such as coronary artery disease and atherosclerotic damage.

In our study, MLX-interacting protein-like (MLXIPL) was linked to SNPs rs2286276 and rs799165 which were SNPs in the GRS of Whites and African Americans. In both racial ancestries we found Carbohydrate-Responsive Element-Binding Protein (CHREBP) was linked with MXIPL which was linked with fructose/mannose metabolism. Fructose as sucrose or high fructose corn syrup is associated with obesity and cardiometabolic risk factors, e.g. high levels of triglycerides, which are features of MetS [81]. Restriction of fructose could be beneficial in controlling MetS [82].

In our study, we found within GRS tertiles, harmful MetS risks were associated with the Western dietary pattern, and protective MetS risks were associated with the high-fat dairy dietary pattern. Given the interaction effects of the GRS and the Western dietary pattern that is high in saturated fat and fructose and low in linoleic fatty acid, individuals who consume a Western dietary pattern who have FAD1/ FAD2 (rs174548) and MLXIPL (rs2286276) genetic mutations may have increased risk for MetS. However, high-fat dairy intake that is high in vitamin A and vitamin D in spite of CYP26A1 (rs4411227) mutation may decrease MetS risk and potentially benefit metabolic health.

An advantage of this study is the longitudinal assessments from which we extracted covariates across four visits. ARIC is a prospective study; therefore, information bias was lessened because data on MetS components (abdominal obesity, high fasting blood glucose, elevated blood pressure, low HDL, and high triglycerides) were ascertained independently of the collection of dietary variables. In addition, there was a large number of cases of MetS at the four visits among both Whites and African Americans. Measurement bias was reduced because of the rigorous nature of the assessment protocol in the ARIC study.

A limitation of our analysis and interpretation is the relatively small sample size for African Americans, especially for the finer strata which may have contributed to type 2 error. Because of the scarcity of genetic studies performed in African Americans, we used SNPs from studies in the NHGRI catalog that were generated using predominantly European ancestry samples. African Americans appear to have more diverse complex genetic pathways than Whites. We believe that with adequate representation of SNPs genotyped in African Americans, the magnitude of effect may have been greater. Another limitation is recall bias. The FFQ was used to quantify information about a person’s intake during the previous year. Some participants may have had difficulty recalling some of the 66 food items accurately, while other foods such as traditional foods eaten by African Americans frequently, may not have been present in the FFQ. If beneficial or harmful foods were eaten frequently, but were not part of the FFQ, then it is possible that the true risk ratio is even lower or higher, respectively than we estimated.

Finally, we did not use a discovery sample population to replicate our results for the GRS due to the limitation of sample size. Neither did we used SNP beta coefficients as weights to replicate our GRS for the following reasons: Because we applied risk ratios in our analyses, we did not used odds ratios from published studies as this could have caused a more substantial bias and overestimated the risk ratios; due to MetS being a highly common disease condition found in this study in both racial ancestry populations. There were some cardiovascular studies that reported hazard ratios in the NHGRI catalog, but because MetS status can change due to improvement or worsening of risk factors, we were very skeptical to use these SNP beta coefficients which were based on risk for development of MetS.

Conclusion

In summary, we were able to show that a GRS composed of risk-raising alleles, and the Western and high-fat dietary patterns were associated with MetS. Through interaction with the GRS, the Western dietary pattern was associated with a profoundly higher risk of development of MetS in Whites and African Americans. However, interaction with the GRS and high-fat dairy pattern was protective against MetS in both racial ancestry groups. These results were very strong for Whites, but less clear for African Americans, warranting further study in a larger sample of African Americans. Future investigations will be important to elucidate specific dietary patterns and dietary components that may confer protection against or risk for MetS based on genetic predisposition.

Supplementary Information

Acknowledgement

Not applicable.

Abbreviations

MetS

Metabolic syndrome

GRS

Genetic risk score

AHA/ACC

American Heart Association/American College of Cardiology

RR

Risk ratios

CI

Confidence intervals

SNP

Single nucleotide polymorphisms

dbGaP

Database of Genotypes and Phenotypes

ARIC

Atherosclerosis Risk in Communities

FFQ

Food frequency questionnaire

NHGRI

National Human Genome Research Institute

GWAS

Genome-wide association studies

BMI

Body mass index

HDL

High density lipoprotein cholesterol

Authors' contributions

DSH conceptualized and designed the study, carried out and supervised the analyses, and drafted the manuscript. SBR, JTG, HTG, and TBM supervised data analyses, critically reviewed the manuscript, and approved the final manuscript as submitted. All authors (DSH, SBR, JTG, HTG, and TBM) approved the final manuscript as submitted. All authors read and approved the final manuscript.

Funding

This work is supported by the following National Heart, Lung, and Blood Institute (NHLBI) Grants: K01 HL127278 to DSH and R01 HL132344 to TBM. The funder’s (NHLBI) role was to financially support the investigators (DSH and TBM) in conducting this research. The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Availability of data and materials

We received access to the data through the NIH controlled dbGaP repository, https://www.ncbi.nlm.nih.gov/gap with accession numbers phs000090 and phs000280. Interested researchers can request the data through this weblink.

Declarations

Ethics approval and consent to participate

All participants signed an informed consent document to participate in the ARIC study. Our research involved secondary data analysis from ARIC, which was approved by the Social & Behavioral Institutional Review Board at Morehouse School of Medicine. The need for consent was waived because all ARIC data were de-identified. Dr. Dale Hardy acquired administrative permissions to access the genetic/phenotypic participant data from Dr. Anne Sturcke, a representative of NCBI, dbGap. Researchers require administrative approval from dbGaP to access genetic/personal participant data.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Dale S. Hardy, Email: Shardy30@aol.com

Jane T. Garvin, Email: bgarvin@augusta.edu

Tesfaye B. Mersha, Email: tesfaye.mersha@cchmc.org

References

  • 1.Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–1132. doi: 10.1016/j.jacc.2010.05.034. [DOI] [PubMed] [Google Scholar]
  • 2.Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008;371(9628):1927–1935. doi: 10.1016/S0140-6736(08)60602-9. [DOI] [PubMed] [Google Scholar]
  • 3.Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245–1250. doi: 10.1161/01.CIR.0000140677.20606.0E. [DOI] [PubMed] [Google Scholar]
  • 4.Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26(4):364–373. doi: 10.1016/j.tcm.2015.10.004. [DOI] [PubMed] [Google Scholar]
  • 5.Park HS, Oh SW, Cho SI, Choi WH, Kim YS. The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol. 2004;33(2):328–336. doi: 10.1093/ije/dyh032. [DOI] [PubMed] [Google Scholar]
  • 6.Bankoski A, Harris TB, McClain JJ, Brychta RJ, Caserotti P, Chen KY, et al. Sedentary activity associated with metabolic syndrome independent of physical activity. Diabetes Care. 2011;34(2):497–503. doi: 10.2337/dc10-0987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.de Oliveira EP, McLellan KC, Vaz de Arruda Silveira L, Burini RC. Dietary factors associated with metabolic syndrome in Brazilian adults. Nutr J. 2012;11:13–20. doi: 10.1186/1475-2891-11-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the atherosclerosis risk in communities study. Circulation. 2008;117(6):754–761. doi: 10.1161/CIRCULATIONAHA.107.716159. [DOI] [PubMed] [Google Scholar]
  • 9.Damiao R, Castro TG, Cardoso MA, Gimeno SG, Ferreira SR, Japanese-Brazilian Diabetes Study Group Dietary intakes associated with metabolic syndrome in a cohort of Japanese ancestry. Br J Nutr. 2006;96(3):532–538. [PubMed] [Google Scholar]
  • 10.Freire RD, Cardoso MA, Gimeno SG, Ferreira SR, Japanese-Brazilian Diabetes Study Group Dietary fat is associated with metabolic syndrome in Japanese Brazilians. Diabetes Care. 2005;28(7):1779–1785. doi: 10.2337/diacare.28.7.1779. [DOI] [PubMed] [Google Scholar]
  • 11.Yoo S, Nicklas T, Baranowski T, Zakeri IF, Yang SJ, Srinivasan SR, et al. Comparison of dietary intakes associated with metabolic syndrome risk factors in young adults: the Bogalusa Heart Study. Am J Clin Nutr. 2004;80(4):841–848. doi: 10.1093/ajcn/80.4.841. [DOI] [PubMed] [Google Scholar]
  • 12.Wirfalt E, Hedblad B, Gullberg B, Mattisson I, Andren C, Rosander U, et al. Food patterns and components of the metabolic syndrome in men and women: a cross-sectional study within the Malmo Diet and Cancer cohort. Am J Epidemiol. 2001;154(12):1150–1159. doi: 10.1093/aje/154.12.1150. [DOI] [PubMed] [Google Scholar]
  • 13.Suliga E, Koziel D, Ciesla E, Gluszek S. Association between dietary patterns and metabolic syndrome in individuals with normal weight: a cross-sectional study. Nutr J. 2015;14:55–65. doi: 10.1186/s12937-015-0045-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Choi JH, Woo HD, Lee JH, Kim J. Dietary patterns and risk for metabolic syndrome in Korean women: a cross-sectional study. Medicine (Baltimore) 2015;94(34):e1424. doi: 10.1097/MD.0000000000001424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mazidi M, Pennathur S, Afshinnia F. Link of dietary patterns with metabolic syndrome: analysis of the National Health and Nutrition Examination Survey. Nutr Diabetes. 2017;7(3):e255. doi: 10.1038/nutd.2017.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Aekplakorn W, Satheannoppakao W, Putwatana P, Taneepanichskul S, Kessomboon P, Chongsuvivatwong V, et al. Dietary pattern and metabolic syndrome in Thai adults. J Nutr Metab. 2015;468759:e1–10. doi: 10.1155/2015/468759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sonnenberg L, Pencina M, Kimokoti R, Quatromoni P, Nam BH, D'Agostino R, et al. Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. Obes Res. 2005;13(1):153–162. doi: 10.1038/oby.2005.20. [DOI] [PubMed] [Google Scholar]
  • 18.Kong S, Cho YS. Identification of female-specific genetic variants for metabolic syndrome and its component traits to improve the prediction of metabolic syndrome in females. BMC Med Genet. 2019;20(1):99–111. doi: 10.1186/s12881-019-0830-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Qi L, Cornelis MC, Zhang C, van Dam RM, Hu FB. Genetic predisposition, Western dietary pattern, and the risk of type 2 diabetes in men. Am J Clin Nutr. 2009;89(5):1453–1458. doi: 10.3945/ajcn.2008.27249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Raghavan S, Porneala B, McKeown N, Fox CS, Dupuis J, Meigs JB. Metabolic factors and genetic risk mediate familial type 2 diabetes risk in the Framingham Heart Study. Diabetologia. 2015;58(5):988–996. doi: 10.1007/s00125-015-3498-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Belsky DW, Moffitt TE, Sugden K, Williams B, Houts R, McCarthy J, et al. Development and evaluation of a genetic risk score for obesity. Biodemography Soc Biol. 2013;59(1):85–100. doi: 10.1080/19485565.2013.774628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wolf EJ, Miller DR, Logue MW, Sumner J, Stoop TB, Leritz EC, et al. Contributions of polygenic risk for obesity to PTSD-related metabolic syndrome and cortical thickness. Brain Behav Immun. 2017;65:328–336. doi: 10.1016/j.bbi.2017.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Zhao X, Xi B, Shen Y, Wu L, Hou D, Cheng H, et al. An obesity genetic risk score is associated with metabolic syndrome in Chinese children. Gene. 2014;535(2):299–302. doi: 10.1016/j.gene.2013.11.006. [DOI] [PubMed] [Google Scholar]
  • 24.Ntalla I, Kanoni S, Zeng L, Giannakopoulou O, Danesh J, Watkins H, et al. Genetic risk score for coronary disease identifies predispositions to cardiovascular and noncardiovascular diseases. J Am Coll Cardiol. 2019;73(23):2932–2942. doi: 10.1016/j.jacc.2019.03.512. [DOI] [PubMed] [Google Scholar]
  • 25.Rosenman JG, Halle JS, Socinski MA, Deschesne K, Moore DT, Johnson H, et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. Int J Radiat Oncol Biol Phys. 2002;54(2):348–356. doi: 10.1016/s0360-3016(02)02958-9. [DOI] [PubMed] [Google Scholar]
  • 26.Kraja AT, Chasman DI, North KE, Reiner AP, Yanek LR, Kilpelainen TO, et al. Pleiotropic genes for metabolic syndrome and inflammation. Mol Genet Metab. 2014;112(4):317–338. doi: 10.1016/j.ymgme.2014.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012;8(3):e1002607. doi: 10.1371/journal.pgen.1002607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kristiansson K, Perola M, Tikkanen E, Kettunen J, Surakka I, Havulinna AS, et al. Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet. 2012;5(2):242–249. doi: 10.1161/CIRCGENETICS.111.961482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kilpelainen TO, Zillikens MC, Stancakova A, Finucane FM, Ried JS, Langenberg C, et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet. 2011;43(8):753–760. doi: 10.1038/ng.866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, Kullo IJ, et al. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes. 2011;60(4):1329–1339. doi: 10.2337/db10-1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Liguori R, Labruna G, Alfieri A, Martone D, Farinaro E, Contaldo F, et al. The FTO gene polymorphism (rs9939609) is associated with metabolic syndrome in morbidly obese subjects from southern Italy. Mol Cell Probes. 2014;28(4):195–199. doi: 10.1016/j.mcp.2014.03.004. [DOI] [PubMed] [Google Scholar]
  • 32.Wang H, Dong S, Xu H, Qian J, Yang J. Genetic variants in FTO associated with metabolic syndrome: a meta- and gene-based analysis. Mol Biol Rep. 2012;39(5):5691–5698. doi: 10.1007/s11033-011-1377-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zhou D, Liu H, Zhou M, Wang S, Zhang J, Liao L, et al. Common variant (rs9939609) in the FTO gene is associated with metabolic syndrome. Mol Biol Rep. 2012;39(6):6555–6561. doi: 10.1007/s11033-012-1484-4. [DOI] [PubMed] [Google Scholar]
  • 34.Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, et al. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation. 2007;116(5):480–488. doi: 10.1161/CIRCULATIONAHA.107.689935. [DOI] [PubMed] [Google Scholar]
  • 35.Nettleton JA, Lutsey PL, Wang Y, Lima JA, Michos ED, Jacobs DR., Jr Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA) Diabetes Care. 2009;32(4):688–694. doi: 10.2337/dc08-1799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Katcher HI, Legro RS, Kunselman AR, Gillies PJ, Demers LM, Bagshaw DM, et al. The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am J Clin Nutr. 2008;87(1):79–90. doi: 10.1093/ajcn/87.1.79. [DOI] [PubMed] [Google Scholar]
  • 37.Nettleton JA, Follis JL, Ngwa JS, Smith CE, Ahmad S, Tanaka T, et al. Genexdietary pattern interactions in obesity: analysis of up to 68,317 adults of European ancestry. Hum Mol Genet. 2015;24(16):4728–4738. doi: 10.1093/hmg/ddv186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ghazizadeh H, Esmaily H, Sharifan P, Parizadeh S, Mohammad R, Ferns G, et al. Interaction between a genetic variant in vascular endothelial growth factor with dietary intakes in association with the main factors of metabolic syndrome. Gene Rep. 2020;21:100813. [Google Scholar]
  • 39.Qi Q, Kilpelainen TO, Downer MK, Tanaka T, Smith CE, Sluijs I, et al. FTO genetic variants, dietary intake and body mass index: insights from 177330 individuals. Hum Mol Genet. 2014;23(25):6961–6972. doi: 10.1093/hmg/ddu411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hardy DS, Racette SB, Hoelscher DM. Macronutrient intake as a mediator with FTO to increase body mass index. J Am Coll Nutr. 2014;33(4):256–266. doi: 10.1080/07315724.2013.879458. [DOI] [PubMed] [Google Scholar]
  • 41.Nettleton JA, Volcik KA, Hoogeveen RC, Boerwinkle E. Carbohydrate intake modifies associations between ANGPTL4[E40K] genotype and HDL-cholesterol concentrations in White men from the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2009;203(1):214–220. doi: 10.1016/j.atherosclerosis.2008.05.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Nettleton JA, Volcik KA, Demerath EW, Boerwinkle E, Folsom AR. Longitudinal changes in triglycerides according to ANGPTL4[E40K] genotype and longitudinal body weight change in the atherosclerosis risk in communities study. Ann Epidemiol. 2008;18(11):842–846. doi: 10.1016/j.annepidem.2008.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.National Center for Biotechnology Information, U.S. National Library of Medicine. http://www.ncbi.nlm.nih.gov/gap/. 19 May 2020.
  • 44.Jackson R, Chambless LE, Yang K, Byrne T, Watson R, Folsom A, et al. Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. J Clin Epidemiol. 1996;49(12):1441–1446. doi: 10.1016/0895-4356(95)00047-x. [DOI] [PubMed] [Google Scholar]
  • 45.Anonymous The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129(4):687–702. [PubMed] [Google Scholar]
  • 46.Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122(1):51–65. doi: 10.1093/oxfordjournals.aje.a114086. [DOI] [PubMed] [Google Scholar]
  • 47.Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J, Cawley S, et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet. 2008;40(10):1253–1260. doi: 10.1038/ng.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.National Institutes of Health. https://www.genome.gov/26525384/catalog-of-published-genomewide-association-studies/4/2011.
  • 49.Chang C. Purcell S. https://www.cog-genomics.org/plink2/3/2019.
  • 50.Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22(9):1790–1797. doi: 10.1101/gr.137323.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Yang J, Lee SH, Goddard ME, Visscher PM. Genome-wide complex trait analysis (GCTA): methods, data analyses, and interpretations. Methods Mol Biol. 2013;1019:215–236. doi: 10.1007/978-1-62703-447-0_9. [DOI] [PubMed] [Google Scholar]
  • 52.Whelton PK, Carey RM, Aronow WS, Casey DE, Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension J Am Coll Cardiol. 2017;71(19):e127–248. doi: 10.1016/j.jacc.2017.11.006. [DOI] [PubMed] [Google Scholar]
  • 53.Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322. doi: 10.1161/CIR.0000000000000152. [DOI] [PubMed] [Google Scholar]
  • 54.Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49(4):403–414. doi: 10.1016/j.jacc.2006.09.032. [DOI] [PubMed] [Google Scholar]
  • 55.Teo K, Lear S, Islam S, Mony P, Dehghan M, Li W, et al. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: The Prospective Urban Rural Epidemiology (PURE) study. JAMA. 2013;309(15):1613–1621. doi: 10.1001/jama.2013.3519. [DOI] [PubMed] [Google Scholar]
  • 56.van der Pol M, Hennessy D, Manns B. The role of time and risk preferences in adherence to physician advice on health behavior change. Eur J Health Econ. 2017;18(3):373–386. doi: 10.1007/s10198-016-0800-7. [DOI] [PubMed] [Google Scholar]
  • 57.Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36(5):936–942. doi: 10.1093/ajcn/36.5.936. [DOI] [PubMed] [Google Scholar]
  • 58.Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 3. New Jersey: John-Wiley & Sons, Inc; 2013. [Google Scholar]
  • 59.Febbo PG, Mulligan MG, Slonina DA, Stegmeir K, Di Vizio D, Martinez PR, et al. Literature Lab: a method of automated literature interrogation to infer biology from microarray analysis. BMC Genomics. 2007;8:461. doi: 10.1186/1471-2164-8-461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Ferdinand KC. Cardiovascular risk reduction in African Americans: current concepts and controversies. Glob Cardiol Sci Pract. 2016;2016(1):e201602. doi: 10.21542/gcsp.2016.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Hardy DS, Garvin JT, Mersha TB, Racette SB. Ancestry specific associations of FTO gene variant and metabolic syndrome: a longitudinal ARIC study. Medicine (Baltimore) 2020;99(6):e18820. doi: 10.1097/MD.0000000000018820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Liu S, Choi HK, Ford E, Song Y, Klevak A, Buring JE, et al. A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care. 2006;29(7):1579–1584. doi: 10.2337/dc06-0256. [DOI] [PubMed] [Google Scholar]
  • 63.Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000;72(4):912–921. doi: 10.1093/ajcn/72.4.912. [DOI] [PubMed] [Google Scholar]
  • 64.Stanhope KL. Sugar consumption, metabolic disease and obesity: the state of the controversy. Crit Rev Clin Lab Sci. 2016;53(1):52–67. doi: 10.3109/10408363.2015.1084990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Seo EH, Kim H, Kwon O. Association between total sugar intake and metabolic syndrome in middle-aged Korean men and women. Nutrients. 2019;11(9):2042–2054. doi: 10.3390/nu11092042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care. 2010;33(11):2477–2483. doi: 10.2337/dc10-1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Kidambi S, Kotchen JM, Krishnaswami S, Grim CE, Kotchen TA. Cardiovascular correlates of insulin resistance in normotensive and hypertensive African Americans. Metabolism. 2011;60(6):835–842. doi: 10.1016/j.metabol.2010.07.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Hu T, Mills KT, Yao L, Demanelis K, Eloustaz M, Yancy WS, Jr, et al. Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2012;176(Suppl 7):S44–54. doi: 10.1093/aje/kws264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Manousopoulou A, Al-Daghri NM, Garbis SD, Chrousos GP. Vitamin D and cardiovascular risk among adults with obesity: a systematic review and meta-analysis. Eur J Clin Invest. 2015;45(10):1113–1126. doi: 10.1111/eci.12510. [DOI] [PubMed] [Google Scholar]
  • 70.Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala NB, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas. 2010;65(3):225–236. doi: 10.1016/j.maturitas.2009.12.013. [DOI] [PubMed] [Google Scholar]
  • 71.Strange RC, Shipman KE, Ramachandran S. Metabolic syndrome: a review of the role of vitamin D in mediating susceptibility and outcome. World J Diabetes. 2015;6(7):896–911. doi: 10.4239/wjd.v6.i7.896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Jaaskelainen T, Knekt P, Suvisaari J, Mannisto S, Partonen T, Saaksjarvi K, et al. Higher serum 25-hydroxyvitamin D concentrations are related to a reduced risk of depression. Br J Nutr. 2015;113(9):1418–1426. doi: 10.1017/S0007114515000689. [DOI] [PubMed] [Google Scholar]
  • 73.Pallet V, Touyarot K. Vitamin A and cognitive processes. Nutr Aging. 2015;2015(3):21–31. [Google Scholar]
  • 74.Sugiura M, Nakamura M, Ogawa K, Ikoma Y, Matsumoto H, Ando F, et al. Associations of serum carotenoid concentrations with the metabolic syndrome: interaction with smoking. Br J Nutr. 2008;100(6):1297–1306. doi: 10.1017/S0007114508978302. [DOI] [PubMed] [Google Scholar]
  • 75.Koletzko B, Reischl E, Tanjung C, Gonzalez-Casanova I, Ramakrishnan U, Meldrum S, et al. FADS1 and FADS2 polymorphisms modulate fatty acid metabolism and dietary impact on health. Annu Rev Nutr. 2019;39:21–44. doi: 10.1146/annurev-nutr-082018-124250. [DOI] [PubMed] [Google Scholar]
  • 76.Smith CE, Follis JL, Nettleton JA, Foy M, Wu JH, Ma Y, et al. Dietary fatty acids modulate associations between genetic variants and circulating fatty acids in plasma and erythrocyte membranes: meta-analysis of nine studies in the CHARGE consortium. Mol Nutr Food Res. 2015;59(7):1373–1383. doi: 10.1002/mnfr.201400734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Lattka E, Illig T, Koletzko B, Heinrich J. Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism. Curr Opin Lipidol. 2010;21(1):64–69. doi: 10.1097/MOL.0b013e3283327ca8. [DOI] [PubMed] [Google Scholar]
  • 78.Martinelli N, Girelli D, Malerba G, Guarini P, Illig T, Trabetti E, et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr. 2008;88(4):941–949. doi: 10.1093/ajcn/88.4.941. [DOI] [PubMed] [Google Scholar]
  • 79.Farvid MS, Ding M, Pan A, Sun Q, Chiuve SE, Steffen LM, et al. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation. 2014;130(18):1568–1578. doi: 10.1161/CIRCULATIONAHA.114.010236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Seah JY, Gay GM, Su J, Tai ES, Yuan JM, Koh WP, et al. Consumption of red meat, but not cooking oils high in polyunsaturated fat, is associated with higher arachidonic acid status in Singapore Chinese Adults. Nutrients. 2017;9(2):2–14. doi: 10.3390/nu9020101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Feinman RD, Fine EJ. Fructose in perspective. Nutr Metab (Lond) 2013;10(1):1–11. doi: 10.1186/1743-7075-10-45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Iizuka K. The role of carbohydrate response element binding protein in intestinal and hepatic fructose metabolism. Nutrients. 2017;9(2):1–12. doi: 10.3390/nu9020181. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

We received access to the data through the NIH controlled dbGaP repository, https://www.ncbi.nlm.nih.gov/gap with accession numbers phs000090 and phs000280. Interested researchers can request the data through this weblink.


Articles from BMC Medical Genomics are provided here courtesy of BMC

RESOURCES